A comparative proteomic study identified calreticulin and prohibitin up-regulated in adrenocortical carcinomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A comparative proteomic study identified calreticulin and prohibitin up-regulated in adrenocortical carcinomas ; volume:8 ; number:1 ; day:15 ; month:4 ; year:2013 ; pages:1-8 ; date:12.2013
Diagnostic pathology ; 8, Heft 1 (15.4.2013), 1-8, 12.2013
- Creator
-
Yang, Ming-shan
- Contributor
-
Wang, Huan-sheng
Wang, Bao-sheng
Li, Wan-hu
Pang, Zeng-fen
Zou, Ben-kui
Zhang, Xin
Shi, Xue-tao
Mu, Dian-bin
Zhang, De-xian
Gao, Yong-sheng
Sun, Xiao-Wen
Xia, Shu-Jie
SpringerLink (Online service)
- DOI
-
10.1186/1746-1596-8-58
- URN
-
urn:nbn:de:1111-2016080742643
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yang, Ming-shan
- Wang, Huan-sheng
- Wang, Bao-sheng
- Li, Wan-hu
- Pang, Zeng-fen
- Zou, Ben-kui
- Zhang, Xin
- Shi, Xue-tao
- Mu, Dian-bin
- Zhang, De-xian
- Gao, Yong-sheng
- Sun, Xiao-Wen
- Xia, Shu-Jie
- SpringerLink (Online service)
Other Objects (12)
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
Fully-automated CT derived body composition analysis reveals sarcopenia in functioning adrenocortical carcinomas
Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
ITRAQ-based proteomic analysis reveals possible target-related proteins in human adrenocortical adenomas
Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining
Proteomic analysis of urinary fibrinogen degradation products in patients with urothelial carcinomas
Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues
Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
Proteomic analysis identified potential age‐associated prognostic biomarkers in pneumonia‐derived paediatric sepsis
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
Fully-automated CT derived body composition analysis reveals sarcopenia in functioning adrenocortical carcinomas
Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
ITRAQ-based proteomic analysis reveals possible target-related proteins in human adrenocortical adenomas
Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining
Proteomic analysis of urinary fibrinogen degradation products in patients with urothelial carcinomas
Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues
Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
Proteomic analysis identified potential age‐associated prognostic biomarkers in pneumonia‐derived paediatric sepsis
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
Fully-automated CT derived body composition analysis reveals sarcopenia in functioning adrenocortical carcinomas
Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
ITRAQ-based proteomic analysis reveals possible target-related proteins in human adrenocortical adenomas
Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining
Proteomic analysis of urinary fibrinogen degradation products in patients with urothelial carcinomas
Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues
Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening